{"id":867566,"date":"2025-07-08T15:22:05","date_gmt":"2025-07-08T19:22:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/"},"modified":"2025-07-08T15:22:05","modified_gmt":"2025-07-08T19:22:05","slug":"investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/","title":{"rendered":"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 8, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Moore Law,\u00a0PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against:<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg\" title=\"logo (PRNewsfoto\/Moore Kuehn, PLLC)\" alt=\"logo (PRNewsfoto\/Moore Kuehn, PLLC)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<ul type=\"disc\">\n<li>\n          <b><br \/>\n            <u>Hims &amp; Hers Health, Inc. (NYSE: HIMS)<\/u><br \/>\n          <\/b><\/p>\n<ul type=\"disc\">\n<li>Shareholders should email\u00a0<a href=\"mailto:Fletcher@fmoorelaw.com\" target=\"_blank\" rel=\"nofollow\">Fletcher@fmoorelaw.com<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>The investigation concerns a recent announcement about the Novo Nordisk collaboration.<\/p>\n<p>On\u00a0April 29, 2025, Hims &amp; Hers announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of &#8220;a bundled offering of Novo Nordisk&#8217;s FDA-approved Wegovy\u00ae on the Hims &amp; Hers platform.&#8221; Then, on\u00a0June 23, 2025, Novo\u00a0Nordisk issued a press release announcing that it was terminating its partnership with Hims &amp; Hers, citing &#8220;Hims &amp; Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy\u00ae that put patient safety at risk.&#8221; The press release stated that\u00a0Hims &amp; Hers &#8220;has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of &#8216;personalization.&#8221;&#8217; The press release further stated that &#8220;[b]ased on Novo Nordisk&#8217;s investigation, the &#8216;semaglutide&#8217; active pharmaceutical ingredients that are in the knock-off drugs sold by telehealth entities and compounding pharmacies are manufactured by foreign suppliers in\u00a0China&#8221; which &#8220;FDA has never authorized or approved and which may contain unsafe and illicit foreign ingredients.&#8221;\u00a0<\/p>\n<p>On this news, Hims &amp; Hers&#8217; stock price fell\u00a0$22.24\u00a0per share, or 34.63%, to close at\u00a0$41.98\u00a0per share on\u00a0June 23, 2025.<\/p>\n<p>If you own\u00a0<b><u>Hims &amp; Hers Health, Inc. (NYSE: HIMS)<\/u><\/b> stock, please contact\u00a0Fletcher Moore by email at\u00a0<a href=\"mailto:fletcher@fmoorelaw.com\" target=\"_blank\" rel=\"nofollow\">fletcher@fmoorelaw.com<\/a>.<\/p>\n<p>You may be able to seek monetary damages, corporate governance reforms, reimbursement to the company, and a court approved incentive award at no cost to you whatsoever. <b><i>All representation is on a contingency fee basis. Shareholders pay no fees or expenses.<\/i><\/b><\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prnpr2 prnpl2 prnvab prnsbtb0 prnrbrb0 prnsbbb0 prnsblb0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">MOORE LAW PLLC<\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">30 Wall Street, 8<sup>th<\/sup> Floor<\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">New York, NY 10005<br \/>(212) 709-8245<br \/><a href=\"mailto:fletcher@fmoorelaw.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">fletcher@fmoorelaw.com<\/a><\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">www.fmoorelaw.com<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY26237&amp;sd=2025-07-08\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims--hers-health-inc-to-contact-law-firm-302500435.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims&#8211;hers-health-inc-to-contact-law-firm-302500435.html<\/a><\/p>\n<p>SOURCE  Moore Law PLLC<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY26237&amp;Transmission_Id=202507081519PR_NEWS_USPR_____NY26237&amp;DateId=20250708\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , July 8, 2025 \/PRNewswire\/ &#8212; Moore Law,\u00a0PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against: Hims &amp; Hers Health, Inc. (NYSE: HIMS) Shareholders should email\u00a0Fletcher@fmoorelaw.com The investigation concerns a recent announcement about the Novo Nordisk collaboration. On\u00a0April 29, 2025, Hims &amp; Hers announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of &#8220;a bundled offering of Novo Nordisk&#8217;s FDA-approved Wegovy\u00ae on the Hims &amp; Hers platform.&#8221; Then, on\u00a0June 23, 2025, Novo\u00a0Nordisk issued a press release announcing that it was terminating its partnership with Hims &amp; Hers, citing &#8220;Hims &amp; Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy\u00ae that put patient safety at risk.&#8221; &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-867566","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , July 8, 2025 \/PRNewswire\/ &#8212; Moore Law,\u00a0PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against: Hims &amp; Hers Health, Inc. (NYSE: HIMS) Shareholders should email\u00a0Fletcher@fmoorelaw.com The investigation concerns a recent announcement about the Novo Nordisk collaboration. On\u00a0April 29, 2025, Hims &amp; Hers announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of &#8220;a bundled offering of Novo Nordisk&#8217;s FDA-approved Wegovy\u00ae on the Hims &amp; Hers platform.&#8221; Then, on\u00a0June 23, 2025, Novo\u00a0Nordisk issued a press release announcing that it was terminating its partnership with Hims &amp; Hers, citing &#8220;Hims &amp; Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy\u00ae that put patient safety at risk.&#8221; &hellip; Continue reading &quot;INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-08T19:22:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm\",\"datePublished\":\"2025-07-08T19:22:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/\"},\"wordCount\":335,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/698123\\\/Moore_Kuehn_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/\",\"name\":\"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/698123\\\/Moore_Kuehn_Logo.jpg\",\"datePublished\":\"2025-07-08T19:22:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/698123\\\/Moore_Kuehn_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/698123\\\/Moore_Kuehn_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm - Market Newsdesk","og_description":"PR Newswire NEW YORK , July 8, 2025 \/PRNewswire\/ &#8212; Moore Law,\u00a0PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against: Hims &amp; Hers Health, Inc. (NYSE: HIMS) Shareholders should email\u00a0Fletcher@fmoorelaw.com The investigation concerns a recent announcement about the Novo Nordisk collaboration. On\u00a0April 29, 2025, Hims &amp; Hers announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of &#8220;a bundled offering of Novo Nordisk&#8217;s FDA-approved Wegovy\u00ae on the Hims &amp; Hers platform.&#8221; Then, on\u00a0June 23, 2025, Novo\u00a0Nordisk issued a press release announcing that it was terminating its partnership with Hims &amp; Hers, citing &#8220;Hims &amp; Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy\u00ae that put patient safety at risk.&#8221; &hellip; Continue reading \"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-08T19:22:05+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm","datePublished":"2025-07-08T19:22:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/"},"wordCount":335,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/","name":"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg","datePublished":"2025-07-08T19:22:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-action-notice-moore-law-pllc-encourages-investors-in-hims-hers-health-inc-to-contact-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims &amp; Hers Health Inc. to Contact Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=867566"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867566\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=867566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=867566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=867566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}